| 000 | 01026 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250513233021.0 | ||
| 264 | 0 | _c20010426 | |
| 008 | 200104s 0 0 fre d | ||
| 022 | _a0003-4266 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDavignon, J | |
| 245 | 0 | 0 |
_a[Mechanisms of action of statins and their pleiotropic effects]. _h[electronic resource] |
| 260 |
_bAnnales d'endocrinologie _cFeb 2001 |
||
| 300 |
_a101-12 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article; Review | ||
| 650 | 0 | 4 |
_aArteriosclerosis _xcomplications |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 |
_aEndothelium, Vascular _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aInflammation _xcomplications |
| 650 | 0 | 4 |
_aLovastatin _xpharmacology |
| 650 | 0 | 4 |
_aNeoplasms _xpathology |
| 650 | 0 | 4 |
_aOsteoporosis _xdrug therapy |
| 700 | 1 | _aMabile, L | |
| 773 | 0 |
_tAnnales d'endocrinologie _gvol. 62 _gno. 1 Pt 2 _gp. 101-12 |
|
| 999 |
_c11177545 _d11177545 |
||